Newsletters - June - July 2005

Newsletters - June - July 2005

Sabinsa Corporation has launched a new trade advertising campaign for Selenium SeLECT®, its branded L-(+)-Selenomethionine ingredient. An advertisement, which began running in June 2005, in select business trade print outlets, features a field of red tulips with a single yellow tulip representing Selenium SeLECT, followed by the tagline 'When the National Cancer Institute began its study of selenium, it could only choose one.' The advertisement was developed as part of a comprehensive marketing campaign.

"This advertising campaign reflects the fact that Selenium SeLECT stands alone in terms of quality, bioavailability and purity in the field of selenium ingredients currently available," stated Hame Persaud , senior vice president of sales and marketing, Sabinsa Corporation. "We want manufacturers and retailers to know that Selenium SeLECT was chosen by the National Cancer Institute to be used in several of its own studies, which is a testament to the superior quality and efficacy of our material."

In addition to this advertisement, Sabinsa has redesigned www.seleniumselect.com, adding updated information on Selenium SeLECT, as well as recent research findings on the role of selenium in health and wellness.

Visit www.seleniumselect.com

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.